这是一项采用非劣效性设计的随机对照试验，受试者按1:1随机分配至水蒸气热治疗（REZUM）组或前列腺尿道提升术（UroLift）组。
适应症：Prostate Cancer
入组条件
纳入标准
- Male ≥ 50 years Symptomatic BPH International prostate symptom score (IPSS) ≥13 Prostate volume 30-80ml
排除标准
- History or high suspicion of prostate cancer
- Current urinary tract infection
- Refractory urinary retention or post-void residual (PVR) ≥250 mL
- Intravesical prostatic protrusion (IPP)\>10mm
- Prior prostate surgery
- Known or suspected allergy to nickel, titanium, or polyester/polypropylene
- Urethral stricture, meatal stenosis, bladder neck contracture
- Neurogenic bladder and/or sphincter abnormalities
入组条件维持 ClinicalTrials.gov 原始英文登记资料，实际入组资格以研究团队的正式评估与受试者知情同意书为准。资料来源：ClinicalTrials.gov，每两周自动更新，最后同步：2026年10月8日。